Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Chi Leung Chiang"'
Publikováno v:
JAMA Network Open
Key Points Question Is pembrolizumab a cost-effective second-line therapy for advanced hepatocellular carcinoma from the US perspective? Findings In this economic evaluation of data from the KEYNOTE-240 randomized trial, the incremental number of qua